What is the recommended work‑up for a reproductive‑age woman (15–45 years) presenting with menstrual irregularities, hirsutism, acne, or infertility to evaluate for polycystic ovarian syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PCOS Work-Up in Reproductive-Age Women

Diagnose PCOS when two of three criteria are met: androgen excess, ovulatory dysfunction, or polycystic ovaries on ultrasound—but first exclude thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia in all women. 1

Essential Diagnostic Criteria

The Rotterdam criteria require any 2 of 3 findings 1:

  • Androgen excess (clinical or biochemical)
  • Ovulatory dysfunction (oligomenorrhea/amenorrhea)
  • Polycystic ovaries on ultrasound

Critical Exclusions (Must Rule Out First)

Mandatory screening for all women 1:

  • TSH → exclude thyroid disease
  • Prolactin → exclude hyperprolactinemia
  • 17-hydroxyprogesterone (17-OHP) → exclude nonclassic congenital adrenal hyperplasia (21-hydroxylase deficiency)

Additional exclusions in select women with amenorrhea or severe phenotypes 1:

  • Cushing syndrome
  • Androgen-secreting tumors
  • Other causes of anovulation

Physical Examination Components

Document the following 1:

  • Terminal hair growth (hirsutism—use standardized scoring)
  • Acne distribution and severity
  • Alopecia (androgenic pattern)
  • Acanthosis nigricans (neck, axillae, groin)
  • Skin tags
  • BMI and waist circumference (abdominal adiposity assessment)

Laboratory Work-Up

Androgen Assessment

Measure circulating androgens 1, 2:

  • Total and free testosterone
  • Sex hormone-binding globulin (SHBG)
  • Consider DHEA-S if virilization present

Ovulatory Status

  • Menstrual history is primary screening tool 1
  • Midluteal progesterone if eumenorrheic but anovulation suspected 1

Metabolic Screening

Oral glucose tolerance test (OGTT) with insulin levels 1—this is critical as women with PCOS have increased risk of type 2 diabetes and metabolic syndrome

Imaging

Transvaginal ultrasound for polycystic ovary morphology 1, 2

  • Not required if both androgen excess and ovulatory dysfunction already present
  • Do NOT use ultrasound for endometrial thickness screening routinely 1

Special Population: Adolescents (Ages 15-19)

Diagnosis requires BOTH 1, 3:

  • Clinical and/or biochemical hyperandrogenism (after exclusion of other pathologies)
  • Persistent oligomenorrhea (irregular cycles beyond 2 years post-menarche)

Do NOT use 1, 4:

  • Anovulatory symptoms alone (normal in early puberty)
  • Polycystic ovary morphology alone (common in normal adolescent development)
  • AMH levels (limited specificity in adolescents) 4

Additional Screening Based on Risk Profile

Mental Health

Screen by history for 1:

  • Depression
  • Anxiety Refer for treatment if identified

Sleep Disorders

In overweight/obese women, screen for 1:

  • Obstructive sleep apnea symptoms
  • Obtain polysomnography if positive

Fertility Assessment

If seeking pregnancy 1:

  • Confirm ovulatory status
  • Exclude other infertility causes beyond anovulation (tubal factors, male factor, etc.)

Metabolic Monitoring

  • Do NOT routinely screen for NAFLD/NASH 1
  • Do screen for obesity, insulin resistance, and diabetes risk

Common Pitfalls to Avoid

  1. Overdiagnosis in adolescents: Irregular cycles and polycystic ovaries are physiologic in early puberty—require persistent findings 1, 3

  2. Missing alternative diagnoses: Always exclude thyroid disease, hyperprolactinemia, and CAH before confirming PCOS 1

  3. Relying on ultrasound alone: PCO morphology without clinical/biochemical findings is insufficient 1

  4. Neglecting metabolic screening: OGTT is recommended, not just fasting glucose 1

  5. Forgetting mental health: Depression and anxiety are significantly increased—screen proactively 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.